Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Salivary Immunoassay Diagnoses Dengue Fever

By LabMedica International staff writers
Posted on 18 May 2011
An antigen capture technique has been used to test the saliva of febrile patients for the presence of dengue virus (DENV) antibodies. More...


This assay, which detects the specific immunoglobulin A (IgA) of DENV in salivary samples, has been evaluated in the early phases of a dengue infection.

Scientists at the Environmental Health Institute, Singapore National Environment Agency (Singapore, Singapore) have developed an antigen capture anti-DENV IgA (ACA) enzyme-linked immunosorbent assay (ELISA) technique for the diagnosis of dengue fever. They collected 69 saliva samples from dengue-confirmed patients at three time points, using Oracol saliva collection swabs (Malvern Medical Development Ltd., Barbourne UK). Blood samples were collected at the same time.

The ACA-ELISA on saliva had an overall sensitivity of 70% in the first three days after fever onset and subsequently rose to over 90% between the third day and eighth day following fever onset. The same technique on sera gave similar results. The sensitivity of ACA-ELISA in saliva was higher than that of the PanBio immunoglobulin M (IgM) Capture ELISA (Alere Inc., Waltham, MA, USA), on sera. The IgM assay detected only 10% of the dengue-confirmed patients after one to three days of fever, and only rose to around 90% after six days of fever. The specificity of the ACA-ELISA test was also found to be high at 97%. Among the 75 DENV-negative control patients, only one patient tested positive, at day seven and day 27, respectively.

The investigators noted that the saliva assay eliminates the need to collect blood from dengue-suspected patients and is painless, nonintrusive, and reduces the risk of needle stick injury. Moreover, the ELISA-based technique is simple and cost effective. Patients, especially the very young and the old, will be more willing to undergo a dengue test. Together, these benefits can potentially improve surveillance and early detection of cases, which in turn can translate to prompt dengue control effort. Due to its high sensitivity among secondary dengue infections, this technique could be very useful in highly endemic areas where the majority of the dengue cases are secondary. Dengue fever is the most common identifiable cause of acute febrile illness among travelers returning from South America, South Central Asia, Southeast Asia, and the Caribbean. The study was published online on May 10, 2011, in the Public Library of Science (PLoS) journal Neglected Tropical Diseases.

Related Links:

Singapore National Environment Agency
Malvern Medical Development Ltd.
Alere Inc.



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.